免疫检测市场规模、份额和成长分析（按产品、技术、检体、应用、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，全球免疫检测市场规模将达到 351.2 亿美元，到 2025 年将达到 370.8 亿美元，到 2033 年将达到 573 亿美元，预测期（2026-2033 年）的复合年增长率为 5.59%。

全球免疫检测市场正经历显着成长，这主要得益于技术进步、诊断测试需求的成长以及在环境检测和临床诊断生物製药领域应用范围的扩大。然而，检测法的变异性以及开发复杂免疫检测的高成本等挑战可能会阻碍市场成长。创新免疫检测的开发需要大量投资，这对该领域的许多公司构成了障碍。儘管存在这些挑战，人们对个人化医疗日益增长的兴趣，以及来自公共和公共部门不断增加的研究经费，可能会加速免疫检测的应用，从而创造新的机会。

推动全球免疫检测市场发展的因素

由于旨在促进医疗发展和研究的组织和政府机构不断增加财政支持，全球免疫检测市场正经历显着成长。资金的激增推动了创新免疫检测解决方案的研发和改进。此外，私营部门对治疗和诊断研究的持续投入也进一步刺激了对这些先进解决方案的需求。私人投资与政府支持的相互作用，成为推动免疫检测市场发展和演进的强大催化剂，促进了更有效的医疗技术和调查方法的发展。

全球免疫检测市场面临的限制因素

由于医疗基础设施匮乏和对免疫检测技术认知度低，全球免疫检测市场在某些发展中地区面临严峻挑战。这种认知不足会阻碍市场成长，因为潜在使用者无法充分了解这些技术的优势。此外，该领域对教育和培训的需求也构成了经济和后勤方面的障碍，进一步加剧了这一局面。缺乏能够解读结果并有效操作免疫检测的专业人员也限制了市场渗透率，抑制了整体需求，最终影响了该细分市场的成长潜力。

全球免疫检测市场趋势

全球免疫检测市场正经历显着成长，这主要得益于感染疾病和慢性病的日益增多，这些疾病需要有效的疾病监测和检测解决方案。免疫检测正成为生物製药领域的重要工具，有助于治疗监测和新药研发。此外，免疫分析在环境监测领域的应用范围不断扩大，尤其是在污染物和有害物质的识别方面，也提升了该市场的重要性。这些多元化的需求推动了市场的动态发展，凸显了免疫检测在医疗保健和环境领域的多功能性和重要性，并使其成为诊断和监测解决方案领域的主要发展趋势。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 专利分析

全球免疫检测市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 试剂和试剂盒
  • ELISA试剂和试剂盒
  • CLIA试剂和试剂盒
  • IFA试剂和试剂盒
  • 快速检测试剂和试剂盒
  • ELISpot试剂和试剂盒
  • 西方墨点法试剂与试剂盒
  • 其他试剂和试剂盒
• 分析器
  • 按类型
  • 开放式系统
  • 封闭式系统
  • 透过购买方式
  • 租赁购买
  • 大量购买

全球免疫检测市场规模（依技术及复合年增长率划分）（2026-2033 年）

• ELISA
• 化学冷光免疫检测（CLIA）
• 萤光（IFA）
• 快速检测
• ELISpot
• 蛋白质印迹法
• 其他的

全球免疫检测市场规模（按检体和复合年增长率划分）（2026-2033 年）

• 血
• 唾液
• 尿
• 其他的

全球免疫检测市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 感染疾病
• 内分泌学
• 肿瘤学
• 骨骼和矿物质代谢紊乱
• 心臟病学
• 血液筛检
• 自体免疫疾病
• 过敏诊断
• 毒理学
• 新生儿筛检
• 其他的

全球免疫检测市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院诊所
• 临床检查室
• 製药生物技术公司和合约研究组织
• 血库
• 研究与学术实验室
• 居家医疗

全球免疫检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

  主要企业简介

  • 雅培实验室（美国）
  • F. Hoffmann-La Roche AG（瑞士）
  • 赛默飞世尔科技公司（美国）
  • 西门子医疗股份公司（德国）
  • 丹纳赫公司（美国）
  • 贝克顿·迪金森公司（BD）（美国）
  • Bio-Rad Laboratories, Inc.（美国）
  • 凯杰公司（德国/荷兰）
  • Sysmex公司（日本）
  • 默克集团（德国）
  • 迪亚索林公司（义大利）
  • 生物梅里埃公司（法国）
  • QuidelOrtho 公司（美国）
  • 安捷伦科技公司（美国）
  • Hologic公司（美国）
  • 珀金埃尔默公司（美国）
  • Luminex公司（美国）
  • 奥特博诊断有限公司（中国）
  • 贝克曼库尔特公司（美国）
  • 兰道克斯实验室（英国）

结论与建议

Global Immunoassay Market size was valued at USD 35.12 Billion in 2024 and is poised to grow from USD 37.08 Billion in 2025 to USD 57.3 Billion by 2033, growing at a CAGR of 5.59% during the forecast period (2026-2033).

The global immunoassay market is experiencing noteworthy expansion, driven by advancements in technology, increasing demand for diagnostic testing, and a broadening of applications across environmental testing, clinical diagnostics, and biopharmaceuticals. However, challenges such as assay variability and the high costs associated with the development of complex immunoassays can hinder market growth. The development of innovative immunoassays requires substantial investment, presenting a barrier for many players in the field. Despite these challenges, opportunities are emerging, particularly with the rising interest in personalized medicine, which is likely to boost the utilization of immunoassays, alongside increased funding for research initiatives from both private and public sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunoassay Market Segments Analysis

Global Immunoassay Market is segmented by Product, Technology, Specimen, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits and Analyzers. Based on Technology, the market is segmented into ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting and Other Technologies. Based on Specimen, the market is segmented into Blood, Saliva, Urine and Other Specimens. Based on Application, the market is segmented into Infectious Diseases, Endocrinology,Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening and Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunoassay Market

The Global Immunoassay market is experiencing significant growth due to increased financial support from both organizations and government entities aimed at advancing healthcare development and research. This surge in funding fosters the creation and enhancement of innovative immunoassay solutions. Additionally, heightened investments from the private sector in both therapeutic and diagnostic research are further propelling the demand for these advanced solutions. The interplay of private investments and supportive government initiatives is thus acting as a powerful catalyst for the expansion and evolution of the immunoassay market, facilitating the development of more effective healthcare technologies and methodologies.

Restraints in the Global Immunoassay Market

The global immunoassay market faces significant challenges in certain developing regions due to inadequate healthcare infrastructure and a general lack of awareness regarding immunoassay techniques. This limited understanding can hinder market growth, as potential users may not fully appreciate the benefits of these technologies. Additionally, the need for education and training in this area can present financial and logistical obstacles, further complicating the situation. The scarcity of skilled professionals capable of interpreting results and effectively operating immunoassays also restricts market adoption and diminishes overall demand, ultimately impacting the growth potential of this market segment.

Market Trends of the Global Immunoassay Market

The Global Immunoassay market is witnessing significant growth driven by the increasing prevalence of infections and chronic diseases necessitating effective disease monitoring and detection solutions. Immunoassays are becoming essential tools for the biopharmaceutical sector, facilitating therapeutic monitoring and the development of novel drugs. Additionally, their expanding applications in environmental monitoring-particularly for identifying pollutants and contaminants-are enhancing their market relevance. This multi-faceted demand is contributing to the market's dynamic evolution, highlighting the versatility and critical importance of immunoassays across healthcare and environmental sectors, thus establishing it as a key trend in the landscape of diagnostics and monitoring solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Immunoassay Market Size by Product & CAGR (2026-2033)

• Market Overview
• Reagents & Kits
  • ELISA Reagents & Kits
  • CLIA Reagents & Kits
  • IFA Reagents & Kits
  • Rapid Test Reagent & Kits
  • ELISpot Reagent & Kits
  • Western Blot Reagent & Kits
  • Other Reagents & Kits
• Analyzers
  • By Type
  • Open-ended Systems
  • Closed-ended Systems
  • By Purchase Mode
  • Rental Purchase
  • Outright Purchase

Global Immunoassay Market Size by Technology & CAGR (2026-2033)

• Market Overview
• ELISA
• Chemiluminescence Immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Rapid Tests
• ELISpot
• Western Blotting
• Other Technologies

Global Immunoassay Market Size by Specimen & CAGR (2026-2033)

• Market Overview
• Blood
• Saliva
• Urine
• Other Specimens

Global Immunoassay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infectious Diseases
• Endocrinology
• Oncology
• Bone & Mineral Disorders
• Cardiology
• Blood Screening
• Autoimmune Disorders
• Allergy Diagnostics
• Toxicology
• Newborn Screening
• Other Applications

Global Immunoassay Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies and CROs
• Blood Banks
• Research & Academic Laboratories
• Home Care Settings

Global Immunoassay Market Size & CAGR (2026-2033)

• North America (Product, Technology, Specimen, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Specimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Specimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Specimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Specimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autobio Diagnostics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations